A carregar...
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
Sarcomas are malignant tumors accounting for a high percentage of cancer morbidity and mortality in children and young adults. Surgery and radiation therapy are the accepted treatments for most sarcomas; however, patients with metastatic disease are treated with systemic chemotherapy. Many tumors di...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341855/ https://ncbi.nlm.nih.gov/pubmed/27563810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11475 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|